首页> 外文期刊>Microbiology Insights >Distribution and Resistance Trends of Community Associated Urinary Tract Pathogens in Sharjah, UAE
【24h】

Distribution and Resistance Trends of Community Associated Urinary Tract Pathogens in Sharjah, UAE

机译:阿联酋沙迦社区相关尿路病原菌的分布和耐药趋势

获取原文
           

摘要

Objective: To describe the spectrum of etiologic agents causing community associated UTI and their antimicrobial resistance trends in a large teaching hospital in Sharjah, United Arab Emirates. Methods: A retrospective review of the microbiology laboratory records of four hundred ninety two cases of community associated UTI between April 2006 and March 2007 was carried out. Etiologic agents and their antimicrobial susceptibility pattern were analyzed. Results: A wide spectrum of uropathogens was isolated of which the leading etiologic agents of community associated UTI were Escherichia coli (207 strains) and Klebsiella species (90 strains). Sixty-six per cent of Gram-negative bacilli were resistant to amoxicillin, 58.5% were resistant to trimethoprim-sulfamethoxazole and more than 50% were resistant to cephalexin. How- ever, resistance rate to antimicrobials like ciprofloxacin and ceftriaxone remain relatively low 9.7% and 7.6% respectively. Conclusions: Escherichia coli remains the leading cause of community associated UTI. In-vitro antimicrobial resistance pattern of the isolates revealed that trimethoprim-sulfamethoxazole, cephalexin and amoxycillin the commonly used first- line antimicrobials were becoming less and less effective in their treatment. This information can help in changing preferences of suitable antimicrobial agent in treatment of community associated UTI.
机译:目的:描述阿拉伯联合酋长国沙迦一家大型教学医院中引起社区相关性尿路感染的病原体谱及其抗菌素耐药性趋势。方法:回顾性分析2006年4月至2007年3月间942例社区相关性UTI的微生物学实验室记录。分析了病因及其抗菌药敏模式。结果:分离出了多种尿路致病菌,其中社区相关性尿路感染的主要病原体为大肠杆菌(207株)和克雷伯菌(90株)。 66%的革兰氏阴性杆菌对阿莫西林耐药,58.5%对甲氧苄氨嘧啶磺胺甲恶唑耐药,50%以上对头孢氨苄耐药。但是,对环丙沙星和头孢曲松等抗菌药的耐药率分别保持在9.7%和7.6%的较低水平。结论:大肠杆菌仍然是社区相关性尿路感染的主要原因。分离株的体外抗药性模式显示,常用的一线抗微生物药甲氧苄氨嘧啶,磺胺甲恶唑,头孢氨苄和阿莫西林在其治疗中越来越不起作用。该信息可以帮助改变在社区相关性UTI治疗中合适的抗菌剂的偏爱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号